JPMORGAN CHASE & CO - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$02580.0%0.00%
Q4 2021$0
-100.0%
258
-96.4%
0.00%
Q3 2021$8,000
-97.3%
7,170
-96.3%
0.00%
Q2 2021$296,000
-30.0%
191,523
+8.7%
0.00%
Q1 2021$423,000
-22.0%
176,221
-4.2%
0.00%
Q4 2020$542,000
+622.7%
183,922
+281.1%
0.00%
Q3 2020$75,000
-35.9%
48,256
+2.3%
0.00%
Q2 2020$117,000
+42.7%
47,171
+17.6%
0.00%
Q1 2020$82,000
-12.8%
40,125
+31.5%
0.00%
Q4 2019$94,000
+70.9%
30,524
+84.5%
0.00%
Q3 2019$55,000
+27.9%
16,541
+19.3%
0.00%
Q2 2019$43,000
+22.9%
13,860
+13.8%
0.00%
Q1 2019$35,000
-31.4%
12,184
-4.5%
0.00%
Q4 2018$51,000
-5.6%
12,755
+10.3%
0.00%
Q3 2018$54,000
-34.9%
11,567
+14.1%
0.00%
Q2 2018$83,00010,142
+112588.9%
0.00%
Q1 2018$090.0%0.00%
Q4 2017$090.0%0.00%
Q3 2017$090.0%0.00%
Q2 2017$090.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$23,522,00027.18%
Consonance Capital Management LP 7,576,431$22,350,0002.09%
Wellington Shields & Co., LLC 1,812,769$5,348,0001.92%
Wellington Shields Capital Management, LLC 2,071,765$6,112,0000.82%
Ikarian Capital, LLC 1,268,154$3,741,0000.16%
Sio Capital Management, LLC 203,432$600,0000.12%
Zebra Capital Management LLC 11,182$33,0000.04%
FEDERATED HERMES, INC. 7,000,000$20,650,0000.04%
GSA CAPITAL PARTNERS LLP 52,146$154,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 161,949$478,0000.02%
View complete list of CASI PHARMACEUTICALS INC shareholders